UB Paderborn / Katalog / Suche / in CDI

The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study

Annals of oncology, 2017-12, Vol.28 (12), p.3051-3057

2017

Link zum Volltext

Verfügbarkeit prüfen

Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature

Medical science monitor, 2000-03, Vol.6 (2), p.411

2000

Link zum Volltext

Verfügbarkeit prüfen

Droplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii181

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer : the X-ACT trial

British journal of cancer, 2006-04, Vol.94 (8), p.1122-1129

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor

British journal of cancer, 2009-05, Vol.100 (9), p.1379-1384

2009

Link zum Volltext

Verfügbarkeit prüfen

NSCLC Patients With Brain Metastases Treated With Platinum-Based Doublets as First-Line Therapy: Analyses From the European FRAME Observational Study

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S47-S47

2014

Link zum Volltext

Verfügbarkeit prüfen

1447 POSTER First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study (FRAME)

European journal of cancer (1990), 2011, Vol.47, p.S183-S183

2011

Link zum Volltext

Verfügbarkeit prüfen

Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2006, Vol.51 (1), p.89-96

2006

Link zum Volltext

Verfügbarkeit prüfen

67P Survival of responders to nivolumab (NIVO) + ipilimumab (IPI) as first-line treatment for advanced NSCLC in CheckMate 227, part 1

Annals of oncology, 2020-12, Vol.31, p.S1444-S1445

2020

Link zum Volltext

Verfügbarkeit prüfen

Bone tissue as the site of action of oncological drugs

Contemporary oncology (Poznań, Poland), 2011, Vol.15 (3), p.147

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-13-05: Timing of initiation of neratinib after completion of trastuzumab-based adjuvant therapy in early-stage HER2+ breast cancer: Exploratory analyses from the phase III ExteNET trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-13-05

2018

Link zum Volltext

Verfügbarkeit prüfen

OA05.06 CheckMate 227: Patient-Reported Outcomes of First-Line Nivolumab + Ipilimumab in High Tumor Mutational Burden Advanced NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S332-S332

2018

Link zum Volltext

Verfügbarkeit prüfen

120. Terapia adiuwantowa zaawansowanego raka nerki

Reports of practical oncology and radiotherapy, 2003, Vol.8, p.S231-S231

2003

Link zum Volltext

Verfügbarkeit prüfen

NSCLC Patients With Brain Metastases Treated With Platinum-Based Doublets as First-Line Therapy: Analyses From the European FRAME Observational Study: Metastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S47-S47

2014

Link zum Volltext

Verfügbarkeit prüfen

Nsclc Patients with Brain Metastases Treated with Platinum-Based Doublets As First-Line Therapy: Analyses from the European Frame Observational Study

Annals of oncology, 2014-09, Vol.25, p.iv439

2014

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Patients Treated with Cisplatin or Carboplatin-Based Doublet Chemotherapy in the European Frame Observational Study

Annals of oncology, 2014-09, Vol.25, p.iv437

2014

Link zum Volltext

Verfügbarkeit prüfen

342 Radical radiation therapy in prostatic cancer: does whole pelvic radiotherapy increase the risk of bone-related side-effects?

Radiotherapy and oncology, 2005-09, Vol.76, p.S155-S155

2005

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of the clavicle radiostructure as a tool for estimation of the osteopathic effect of breast cancer chemotherapy

Breast cancer research and treatment, 2002-06, Vol.73 (3), p.189-197

2002

Link zum Volltext

Verfügbarkeit prüfen

Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer

Lung, 2005-02, Vol.183 (1), p.43-52

2005

Link zum Volltext

Verfügbarkeit prüfen

Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases

Przeglad lekarski, 2001, Vol.58 (6), p.498

2001

Link zum Volltext

Verfügbarkeit prüfen

542PDroplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study

Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature

Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis

Droplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer : the X-ACT trial

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor

NSCLC Patients With Brain Metastases Treated With Platinum-Based Doublets as First-Line Therapy: Analyses From the European FRAME Observational Study

1447 POSTER First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study (FRAME)

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer

67P Survival of responders to nivolumab (NIVO) + ipilimumab (IPI) as first-line treatment for advanced NSCLC in CheckMate 227, part 1

Zastosowanie wczesnego badania PET po 1 cyklu ABVD u chorych na chłoniaka Hodgkina (HL) leczonych schematem ABVD – wieloośrodkowe badanie obserwacyjne Polskiej Grupy Badawczej Chłoniaków (PLRG)

Bone tissue as the site of action of oncological drugs

Abstract P1-13-05: Timing of initiation of neratinib after completion of trastuzumab-based adjuvant therapy in early-stage HER2+ breast cancer: Exploratory analyses from the phase III ExteNET trial

OA05.06 CheckMate 227: Patient-Reported Outcomes of First-Line Nivolumab + Ipilimumab in High Tumor Mutational Burden Advanced NSCLC

120. Terapia adiuwantowa zaawansowanego raka nerki

NSCLC Patients With Brain Metastases Treated With Platinum-Based Doublets as First-Line Therapy: Analyses From the European FRAME Observational Study: Metastatic Non-Small Cell Lung Cancer

Nsclc Patients with Brain Metastases Treated with Platinum-Based Doublets As First-Line Therapy: Analyses from the European Frame Observational Study

Analysis of Patients Treated with Cisplatin or Carboplatin-Based Doublet Chemotherapy in the European Frame Observational Study

342 Radical radiation therapy in prostatic cancer: does whole pelvic radiotherapy increase the risk of bone-related side-effects?

Quantitative assessment of the clavicle radiostructure as a tool for estimation of the osteopathic effect of breast cancer chemotherapy

Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer

Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases

542PDroplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer

O-022Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis

Suchergebnisse filtern